Atlas Capital Advisors’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.05M | Sell |
3,741
-99
| -3% | -$26K | 0.11% | 147 |
|
|
2026
Q1 | $1.02M | Hold |
3,840
| – | – | 0.12% | 145 |
|
|
2025
Q4 | $963K | Buy |
+3,840
| New | +$1.02M | 0.11% | 156 |
|
|
2025
Q2 | $1M | Sell |
3,812
-62
| -2% | -$15.1K | 0.12% | 148 |
|
|
2025
Q1 | $902K | Hold |
3,874
| – | – | 0.11% | 156 |
|
|
2024
Q4 | $888K | Hold |
3,874
| – | – | 0.11% | 157 |
|
|
2024
Q3 | $866K | Buy |
3,874
+110
| +3% | +$24.2K | 0.13% | 136 |
|
|
2024
Q2 | $766K | Sell |
3,764
-321
| -8% | -$65.3K | 0.1% | 159 |
|
|
2024
Q1 | $892K | Buy |
4,085
+126
| +3% | +$27.8K | 0.14% | 137 |
|
|
2023
Q4 | $900K | Buy |
3,959
+11
| +0.3% | +$2.31K | 0.13% | 134 |
|
|
2023
Q3 | $794K | Sell |
3,948
-647
| -14% | -$136K | 0.13% | 125 |
|
|
2023
Q2 | $953K | Hold |
4,595
| – | – | 0.14% | 113 |
|
|
2023
Q1 | $906K | Sell |
4,595
-26
| -0.6% | -$5.35K | 0.14% | 106 |
|
|
2022
Q4 | $935K | Hold |
4,621
| – | – | 0.16% | 111 |
|
|
2022
Q3 | $813K | Sell |
4,621
-58
| -1% | -$11.9K | 0.15% | 113 |
|
|
2022
Q2 | $942K | Sell |
4,679
-671
| -13% | -$143K | 0.16% | 107 |
|
|
2022
Q1 | $1.21M | Buy |
5,350
+2,253
| +73% | +$530K | 0.19% | 101 |
|
|
2021
Q4 | $836K | Hold |
3,097
| – | – | 0.12% | 138 |
|
|
2021
Q3 | $749K | Buy |
3,097
+71
| +2% | +$17.9K | 0.12% | 140 |
|
|
2021
Q2 | $717K | Buy |
3,026
+83
| +3% | +$18.9K | 0.12% | 156 |
|
|
2021
Q1 | $645K | Buy |
2,943
+113
| +4% | +$22.7K | 0.13% | 161 |
|
|
2020
Q4 | $495K | Sell |
2,830
-2,489
| -47% | -$430K | 0.1% | 181 |
|
|
2020
Q3 | $860K | Sell |
5,319
-258
| -5% | -$40.9K | 0.2% | 113 |
|
|
2020
Q2 | $796K | Sell |
5,577
-72
| -1% | -$9.96K | 0.19% | 123 |
|
|
2020
Q1 | $613K | Buy |
5,649
+548
| +11% | +$79K | 0.18% | 126 |
|
|
2019
Q4 | $741K | Buy |
5,101
+112
| +2% | +$16.2K | 0.18% | 142 |
|
|
2019
Q3 | $720K | Buy |
4,989
+2,625
| +111% | +$383K | 0.22% | 137 |
|
|
2019
Q2 | $351K | Buy |
2,364
+133
| +6% | +$18.6K | 0.12% | 213 |
|
|
2019
Q1 | $293K | Sell |
2,231
-3,603
| -62% | -$444K | 0.11% | 218 |
|
|
2018
Q4 | $633K | Buy |
5,834
+2,073
| +55% | +$278K | 0.25% | 107 |
|
|
2018
Q3 | $555K | Buy |
3,761
+2,211
| +143% | +$336K | 0.19% | 147 |
|
|
2018
Q2 | $246K | Sell |
1,550
-2,495
| -62% | -$377K | 0.09% | 244 |
|
|
2018
Q1 | $562K | Buy |
+4,045
| New | +$594K | 0.17% | 175 |
|
Other funds holding LH
Atlas Capital Advisors's LH Position: Q2 2026 in Review
Atlas Capital Advisors reduced its Labcorp (LH) stake by 2.6% in Q2 2026, selling an estimated $26K and leaving 3,741 shares worth $1.05M. The position accounts for 0.11% of the portfolio, ranked #147.
Atlas Capital Advisors first reported a position in LH in Q1 2018 and has held it in 33 quarters since. The position peaked at $1.21M in Q1 2022. 1,053 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- Atlas Capital Advisors held 3,741 shares of Labcorp worth $1.05M as of Q2 2026.
- Atlas Capital Advisors sold 99 Labcorp shares in Q2 2026, an estimated $26K.
- Labcorp made up 0.11% of Atlas Capital Advisors's portfolio in Q2 2026, its #147 holding.
- Atlas Capital Advisors first reported a position in Labcorp in Q1 2018 and has held it in 33 quarters since.
- Atlas Capital Advisors's Labcorp position peaked at $1.21M in Q1 2022.
- 1,053 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on Atlas Capital Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.